In a second victory for the biotech industry in one year, the Federal Circuit has reinstated its ruling that a company’s isolation of human genetic material, and its process for using that material to determine the effectiveness of certain cancer ...
Tagged with: biotech Federal Circuit genetic testing patent
Read More »